摘要
睾丸生殖细胞肿瘤(TGCT)是15-35岁男性中最常见的恶性肿瘤.由于这些肿瘤的生物学和临床特点,可以作为研究顺铂耐药相关分子机制的合适系统。本文从临床和分子的角度对治疗耐药进行了综述。顺铂耐药是由多种生物学机制决定的,包括肿瘤细胞DNA修复能力的调节、凋亡细胞死亡途径的改变、基因表达途径的解除、表观基因的改变和DNA结合不足等。此外,本文还将TGCT描述为研究肿瘤干细胞在转移过程中的细胞特征的模型系统,并描述了可用于研究TGCT治疗耐药的实验模型。上述各方面有助于阐明顺铂耐药的分子机制,并有助于确定有前途的新的治疗靶点。
关键词: 睾丸生殖细胞肿瘤,顺铂耐药,分子机制,实验模型,癌症,肿瘤干细胞。
图形摘要
Current Cancer Drug Targets
Title:Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical Implications
Volume: 18 Issue: 10
关键词: 睾丸生殖细胞肿瘤,顺铂耐药,分子机制,实验模型,癌症,肿瘤干细胞。
摘要: Testicular germ cell tumors (TGCTs) represent the most common malignancy in men aged 15-35. Due to these tumors’ biological and clinical characteristics, they can serve as an appropriate system for studying molecular mechanisms associated with cisplatin-based treatment resistance. This review describes treatment resistance from clinical and molecular viewpoints. Cisplatin resistance is determined by various biological mechanisms, including the modulation of the DNA repair capacity of cancer cells, alterations to apoptotic cell death pathways, deregulation of gene expression pathways, epigenetic alterations and insufficient DNA binding. Moreover, this review describes TGCTs as a model system that enables the study of the cellular features of cancer stem cells in metastatic process and describes experimental models that can be used to study treatment resistance in TGCTs. All of the abovementioned aspects may help to elucidate the molecular mechanisms underlying cisplatin resistance and may help to identify promising new therapeutic targets.
Export Options
About this article
Cite this article as:
Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical Implications, Current Cancer Drug Targets 2018; 18 (10) . https://dx.doi.org/10.2174/1568009618666180102103959
DOI https://dx.doi.org/10.2174/1568009618666180102103959 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Novel Lily-of-the-Valley Fragrance Contrast Agent for Magnetic Resonance and Fluorescence Imaging of Prostate Cancer Cells
Current Pharmaceutical Biotechnology Biology of PPARγ in Cancer: A Critical Review on Existing Lacunae
Current Molecular Medicine Recent Advancement in Natural Hyaluronidase Inhibitors
Current Topics in Medicinal Chemistry Immobilized Using Nanotechnology of Electron-Beam Synthesis Regulators of Progenitor Cells Functions: Remedies of New Generation for Regenerative Medicine
Recent Patents on Regenerative Medicine Estrogen, Neuroprotection and Neurogenesis after Ischemic Stroke
Current Drug Targets Hydrogel-clay Nanocomposites as Carriers for Controlled Release
Current Medicinal Chemistry MicroRNAs in Tumorigenesis
Current Pharmaceutical Biotechnology Ghetto Poverty and Pollution in Egypt: A Deadly Threat for Western Countries Caused by New and Infectious Mutants. A Cultural, Social and Microbiological Synopsis
Inflammation & Allergy - Drug Targets (Discontinued) Analytical Methods for Metallothionein Detection
Current Analytical Chemistry 1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer’s Disease Mice
Current Alzheimer Research Targeting the Ubiquitin-Proteasome Pathway: An Emerging Concept in Cancer Therapy
Current Topics in Medicinal Chemistry Caveolin-1: A Promising Therapeutic Target for Diverse Diseases
Current Molecular Pharmacology Current Status and Perspectives in Peptide Receptor Radiation Therapy
Current Pharmaceutical Design Anionic Antimicrobial Peptides from Eukaryotic Organisms
Current Protein & Peptide Science Melissa of cinalis and Vitamin E as the Potential Therapeutic Candidates for Reproductive Toxicity Caused by Anti-cancer Drug, Cisplatin, in Male Rats
Recent Patents on Anti-Cancer Drug Discovery Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins
Current Cancer Drug Targets Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications
Current Pharmaceutical Design Reproductive Toxicity of T Cells in Early Life: Abnormal Immune Development and Postnatal Diseases
Current Drug Targets Graphical Abstracts
Letters in Drug Design & Discovery The Application of Single Nucleotide Polymorphism Microarrays in Cancer Research
Current Genomics